Oxford BioDynamics Plc (AIM:OBD)
London · Delayed Price · Currency is GBP · Price in GBX 0.1100
0.00 (0.00%)
Jul 6, 2026, 4:35 PM GMT
Oxford BioDynamics Income Statement
Financials in millions GBP. Fiscal year is October - September.
Millions GBP. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
| 1.2 | 1.1 | 0.64 | 0.51 | 0.15 | 0.34 | |
Revenue Growth (YoY) | 33.37% | 72.17% | 24.71% | 231.17% | -54.84% | -25.22% |
Cost of Revenue | 0.64 | 0.57 | 0.35 | 0.24 | 0.04 | - |
Gross Profit | 0.56 | 0.52 | 0.29 | 0.27 | 0.12 | 0.34 |
Selling, General & Admin | 7.82 | 8.98 | 9.97 | 8.81 | 6.94 | 5.62 |
Research & Development | 0.42 | 0.62 | 0.81 | 0.76 | 0.53 | 0.9 |
Other Operating Expenses | -0.03 | -0.03 | -0.48 | -0.83 | -0.35 | -0 |
Operating Expenses | 10.11 | 11.27 | 12.29 | 10.43 | 8.72 | 7.85 |
Operating Income | -9.55 | -10.75 | -12 | -10.17 | -8.6 | -7.51 |
Interest Expense | -0.18 | -0.31 | -0.23 | -0.21 | -0.2 | -0.11 |
Interest & Investment Income | 0.06 | 0.06 | 0.11 | 0.07 | 0.01 | 0.03 |
Currency Exchange Gain (Loss) | -0.11 | -0.11 | -0.3 | 0.03 | 0.12 | -0.03 |
Other Non Operating Income (Expenses) | - | 0.01 | 1.35 | -1.25 | 1.1 | - |
EBT Excluding Unusual Items | -9.78 | -11.1 | -11.06 | -11.52 | -7.57 | -7.63 |
Gain (Loss) on Sale of Assets | - | - | - | 0.11 | - | - |
Asset Writedown | -0.33 | -0.33 | -0.9 | - | - | - |
Pretax Income | -10.11 | -11.42 | -11.96 | -11.41 | -7.57 | -7.63 |
Income Tax Expense | -0.24 | -0.27 | -0.39 | -0.59 | -0.86 | -0.95 |
Net Income | -9.87 | -11.15 | -11.57 | -10.83 | -6.71 | -6.68 |
Net Income to Common | -9.87 | -11.15 | -11.57 | -10.83 | -6.71 | -6.68 |
Shares Outstanding (Basic) | 2,864 | 1,387 | 256 | 147 | 100 | 93 |
Shares Outstanding (Diluted) | 2,864 | 1,387 | 256 | 147 | 100 | 93 |
Shares Change (YoY) | 393.75% | 442.40% | 73.40% | 47.92% | 7.72% | - |
EPS (Basic) | -0.00 | -0.01 | -0.05 | -0.07 | -0.07 | -0.07 |
EPS (Diluted) | -0.00 | -0.01 | -0.05 | -0.07 | -0.07 | -0.07 |
Free Cash Flow | -7.2 | -7.59 | -10.25 | -8.54 | -5.54 | -8.61 |
Free Cash Flow Per Share | -0.00 | -0.01 | -0.04 | -0.06 | -0.06 | -0.09 |
Gross Margin | 46.70% | 47.67% | 45.44% | 52.16% | 75.33% | 100.00% |
Operating Margin | -799.33% | -981.46% | -1886.48% | -1993.72% | -5585.07% | -2202.93% |
Profit Margin | -825.61% | -1018.54% | -1818.71% | -2122.74% | -4357.14% | -1959.53% |
Free Cash Flow Margin | -602.76% | -693.15% | -1611.95% | -1675.29% | -3597.40% | -2525.22% |
EBITDA | -9.13 | -10.27 | -11.33 | -9.51 | -8 | -6.86 |
D&A For EBITDA | 0.43 | 0.48 | 0.67 | 0.66 | 0.61 | 0.65 |
EBIT | -9.55 | -10.75 | -12 | -10.17 | -8.6 | -7.51 |